PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.35%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
26.53%
Positive gross profit growth while ENPH is negative. John Neff would see a clear operational edge over the competitor.
72.87%
Positive EBIT growth while ENPH is negative. John Neff might see a substantial edge in operational management.
78.67%
Positive operating income growth while ENPH is negative. John Neff might view this as a competitive edge in operations.
62.22%
Positive net income growth while ENPH is negative. John Neff might see a big relative performance advantage.
62.30%
Positive EPS growth while ENPH is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
62.30%
Positive diluted EPS growth while ENPH is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.12%
Share reduction more than 1.5x ENPH's 0.81%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.34%
Diluted share reduction more than 1.5x ENPH's 0.81%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
18.17%
Positive OCF growth while ENPH is negative. John Neff would see this as a clear operational advantage vs. the competitor.
72.30%
Positive FCF growth while ENPH is negative. John Neff would see a strong competitive edge in net cash generation.
68.63%
Positive 10Y revenue/share CAGR while ENPH is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
54.18%
Positive 5Y CAGR while ENPH is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
46.43%
Positive 3Y CAGR while ENPH is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
127.60%
10Y OCF/share CAGR 1.25-1.5x ENPH's 94.92%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
259.76%
5Y OCF/share CAGR above 1.5x ENPH's 94.92%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
606.49%
3Y OCF/share CAGR above 1.5x ENPH's 94.92%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
77.75%
Net income/share CAGR at 75-90% of ENPH's 90.00%. Bill Ackman would press for strategic moves to boost long-term earnings.
-402.72%
Negative 5Y net income/share CAGR while ENPH is 90.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-448.13%
Negative 3Y CAGR while ENPH is 90.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-30.93%
Negative 5Y equity/share growth while ENPH is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-47.25%
Negative 3Y equity/share growth while ENPH is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.59%
Our AR growth while ENPH is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-3.44%
Inventory is declining while ENPH stands at 12.43%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-5.33%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-5.21%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-12.86%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-25.47%
Our R&D shrinks while ENPH invests at 5.78%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-31.19%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.